Sweetch, a digital therapeutics innovator and creator of the precision engagement platform for chronic conditions, today announced it has been named a winner in the 2022 BIG Innovation Awards healthcare category, presented by the Business Intelligence Group.
CB Insights today named Sweetch, a digital therapeutics innovator and creator of the hyper-personalized engagement platform for chronic conditions, to its third annual Digital Health 150, which showcases the 150 most promising private digital health companies in the world.
Sweetch, a digital therapeutics innovator and creator of the hyper-personalized engagement platform for chronic conditions, announced today that Prof. Joseph Kvedar has joined its advisory board. Prof. Kvedar brings a deep understanding of remote health, digital therapeutics, and reimbursement to Sweetch, and will focus on accelerating the commercial rollout and demonstrated positive clinical impact of the […]
Sweetch, a digital therapeutics innovator and creator of the hyper-personalized engagement platform for chronic conditions, announced a partnership with Grupo Fleury, one of Brazil’s leading healthcare providers. Fleury will implement Sweetch as part of the company’s Saúde iD telemedicine services to improve health care outcomes for patients living with chronic conditions as part of a substantial multi-year contract.
Yossi Bahagon, the founder of Sweetch, describes the company’s approach to digital reminders as a mixture of artificial intelligence and emotional intelligence. The app will use AI to analyse “lifeprint” data picked up through a smartphone. Then it delivers messages to when you might be more likely to respond to them and in a “tone […]
Onsite diagnostic testing, online medical visits, and remote monitoring are just the beginning of healthcare moving into the 21st century, giving a whole new meaning to the term “digital transformation.” Startups driving this transformation include […] Sweetch, a clinically validated disease management optimization platform.
Meet our G4A 2020 Partner, Sweetch! Yossi Bahagon, Founder & CEO, talks to Jessica DaMassa of WTF Health about his company’s role in the transformation of healthcare.
Bayer will support five new startup companies as part of the company’s G4A Digital Health Partnerships Program. Focus will be on fostering the development of a digital health ecosystem, while driving forward integrated healthcare solutions in the fields of cardiometabolic and renal diseases, oncology, and women’s health.
Founded in 2014, Sweetch is a clinically validated mobile-health platform that utilizes artificial technology (AI) to significantly increase patients’ engagement and compliance with essential health promotion and chronic disease management recommendations through Just-in-Time Adaptive Intervention.
Sweetch Health, an Artificial Intelligence based platform for prediction, prevention and management of chronic diseases, has announced that healthcare pioneer Prof. David Nash, MD, MBA, Founding Dean Emeritus of the Jefferson College of Population Health has joined the Sweetch Advisory Board.